APO Research
Talk to an analyst

APO RESEARCH · REPORT

Menopause Blood Test

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Menopause Blood Test Market Analysis and Forecast 2026-2032

2 May 2026183 pages

Choose your research edition.

Industry ResearchMenopause Blood Test Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Menopause Blood Test Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Menopause Blood Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Menopause Blood Test Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Menopause Blood Test Market Analysis and Forecast 2026-2032183 pages · $4,950 USD

Market perspective

The global Menopause Blood Test market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Menopause Blood Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Menopause Blood Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Menopause Blood Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Menopause Blood Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Menopause Blood Test include Thriva, MyHealthChecked, Forth, Labcorp OnDemand, Randox, Mina Health, OptimallyMe, Welzo and Quest, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Menopause Blood Test, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Menopause Blood Test, also provides the revenue of main regions and countries. Of the upcoming market potential for Menopause Blood Test, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Menopause Blood Test revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Menopause Blood Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Menopause Blood Test revenue, projected growth trends, production technology, application and end-user industry.

Menopause Blood Test Segment by Company

Thriva

MyHealthChecked

Forth

Labcorp OnDemand

Randox

Mina Health

OptimallyMe

Welzo

Quest

LifeCell

High Trees Clinics

Thorne HealthTech

Everlywell

ZRT Laboratory

Medichecks

Menopause Blood Test Segment by Type

Fingerstick Blood

Venous Blood

Menopause Blood Test Segment by Application

Premenopausal

Postmenopausal

Menopause Blood Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopause Blood Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Menopause Blood Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopause Blood Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Menopause Blood Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Menopause Blood Test company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Menopause Blood Test revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Menopause Blood Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fingerstick Blood Major Player Table 3. Venous Blood Major Player Table 4. Global Menopause Blood Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Premenopausal Major Player Table 6. Postmenopausal Major Player Table 7. Menopause Blood Test Industry Trends Table 8. Menopause Blood Test Industry Drivers Table 9. Menopause Blood Test Industry Opportunities and Challenges Table 10. Menopause Blood Test Industry Restraints Table 11. Global Menopause Blood Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Menopause Blood Test Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Menopause Blood Test Market Share by Region (2021-2026) Table 14. Global Menopause Blood Test Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Menopause Blood Test Market Share by Region (2027-2032) Table 16. Global Menopause Blood Test Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Menopause Blood Test Revenue Market Share by Players (2021-2026) Table 18. Global Menopause Blood Test Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Menopause Blood Test Key Players Headquarters & Area Served Table 20. Global Menopause Blood Test Players, Product Type & Application Table 21. Global Menopause Blood Test Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Menopause Blood Test by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Menopause Blood Test Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Menopause Blood Test Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Menopause Blood Test Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Menopause Blood Test Revenue Market Share by Type (2021-2026) Table 28. Global Menopause Blood Test Revenue Market Share by Type (2027-2032) Table 29. Global Menopause Blood Test Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Menopause Blood Test Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Menopause Blood Test Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Menopause Blood Test Revenue Market Share by Application (2021-2026) Table 33. Global Menopause Blood Test Revenue Market Share by Application (2027-2032) Table 34. Thriva Company Information Table 35. Thriva Business Overview Table 36. Thriva Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Thriva Menopause Blood Test Product Portfolio Table 38. Thriva Recent Development Table 39. MyHealthChecked Company Information Table 40. MyHealthChecked Business Overview Table 41. MyHealthChecked Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. MyHealthChecked Menopause Blood Test Product Portfolio Table 43. MyHealthChecked Recent Development Table 44. Forth Company Information Table 45. Forth Business Overview Table 46. Forth Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Forth Menopause Blood Test Product Portfolio Table 48. Forth Recent Development Table 49. Labcorp OnDemand Company Information Table 50. Labcorp OnDemand Business Overview Table 51. Labcorp OnDemand Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Labcorp OnDemand Menopause Blood Test Product Portfolio Table 53. Labcorp OnDemand Recent Development Table 54. Randox Company Information Table 55. Randox Business Overview Table 56. Randox Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Randox Menopause Blood Test Product Portfolio Table 58. Randox Recent Development Table 59. Mina Health Company Information Table 60. Mina Health Business Overview Table 61. Mina Health Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Mina Health Menopause Blood Test Product Portfolio Table 63. Mina Health Recent Development Table 64. OptimallyMe Company Information Table 65. OptimallyMe Business Overview Table 66. OptimallyMe Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. OptimallyMe Menopause Blood Test Product Portfolio Table 68. OptimallyMe Recent Development Table 69. Welzo Company Information Table 70. Welzo Business Overview Table 71. Welzo Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Welzo Menopause Blood Test Product Portfolio Table 73. Welzo Recent Development Table 74. Quest Company Information Table 75. Quest Business Overview Table 76. Quest Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Quest Menopause Blood Test Product Portfolio Table 78. Quest Recent Development Table 79. LifeCell Company Information Table 80. LifeCell Business Overview Table 81. LifeCell Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. LifeCell Menopause Blood Test Product Portfolio Table 83. LifeCell Recent Development Table 84. High Trees Clinics Company Information Table 85. High Trees Clinics Business Overview Table 86. High Trees Clinics Menopause Blood Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. High Trees Clinics Menopause Blood Test Product Portfolio Table 88. High Trees Clinics Recent Development Table 89. Thorne HealthTech Company Information Table 90. Thorne HealthTech Business Overview Table 91. Thorne HealthTech Menopause Blood Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Thorne HealthTech Menopause Blood Test Product Portfolio Table 93. Thorne HealthTech Recent Development Table 94. Everlywell Company Information Table 95. Everlywell Business Overview Table 96. Everlywell Menopause Blood Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Everlywell Menopause Blood Test Product Portfolio Table 98. Everlywell Recent Development Table 99. ZRT Laboratory Company Information Table 100. ZRT Laboratory Business Overview Table 101. ZRT Laboratory Menopause Blood Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. ZRT Laboratory Menopause Blood Test Product Portfolio Table 103. ZRT Laboratory Recent Development Table 104. Medichecks Company Information Table 105. Medichecks Business Overview Table 106. Medichecks Menopause Blood Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Medichecks Menopause Blood Test Product Portfolio Table 108. Medichecks Recent Development Table 109. North America Menopause Blood Test Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Menopause Blood Test Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Menopause Blood Test Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Menopause Blood Test Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Menopause Blood Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Menopause Blood Test Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Menopause Blood Test Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Menopause Blood Test Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Menopause Blood Test Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Menopause Blood Test Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Menopause Blood Test Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Menopause Blood Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Menopause Blood Test Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Menopause Blood Test Revenue by Country (US$ Million) & (2027-2032) Table 123. China Menopause Blood Test Revenue by Type (2021-2026) & (US$ Million) Table 124. China Menopause Blood Test Revenue by Type (2027-2032) & (US$ Million) Table 125. China Menopause Blood Test Revenue by Application (2021-2026) & (US$ Million) Table 126. China Menopause Blood Test Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Menopause Blood Test Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Menopause Blood Test Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Menopause Blood Test Revenue by Application (2021-2026) & (US$ Million) Table 130. Asia Menopause Blood Test Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Menopause Blood Test Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Menopause Blood Test Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Menopause Blood Test Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Menopause Blood Test Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Menopause Blood Test Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Menopause Blood Test Revenue by Application (2021-2026) & (US$ Million) Table 137. SAMEA Menopause Blood Test Revenue by Application (2027-2032) & (US$ Million) Table 138. SAMEA Menopause Blood Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Menopause Blood Test Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Menopause Blood Test Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Menopause Blood Test Image Figure 2. Global Menopause Blood Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Menopause Blood Test Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fingerstick Blood Image Figure 5. Venous Blood Image Figure 6. Global Menopause Blood Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Menopause Blood Test Market Size Share 2021 VS 2025 VS 2032 Figure 8. Premenopausal Image Figure 9. Postmenopausal Image Figure 10. Global Menopause Blood Test Market Size (US$ Million) & (2021-2032) Figure 11. Global Menopause Blood Test Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Menopause Blood Test Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Menopause Blood Test Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Menopause Blood Test Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Menopause Blood Test Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Menopause Blood Test Revenue Market Share by Type (2021-2032) Figure 18. Global Menopause Blood Test Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Menopause Blood Test Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Menopause Blood Test Revenue Market Share by Application (2021-2032) Figure 21. North America Menopause Blood Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Menopause Blood Test Revenue Share by Type (2021-2032) Figure 23. North America Menopause Blood Test Revenue Share by Application (2021-2032) Figure 24. North America Menopause Blood Test Revenue Share by Country (2021-2032) Figure 25. United States Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Menopause Blood Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Menopause Blood Test Revenue Share by Type (2021-2032) Figure 30. Europe Menopause Blood Test Revenue Share by Application (2021-2032) Figure 31. Europe Menopause Blood Test Revenue Share by Country (2021-2032) Figure 32. Germany Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Menopause Blood Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Menopause Blood Test Revenue Share by Type (2021-2032) Figure 42. China Menopause Blood Test Revenue Share by Application (2021-2032) Figure 43. Asia Menopause Blood Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Menopause Blood Test Revenue Share by Type (2021-2032) Figure 45. Asia Menopause Blood Test Revenue Share by Application (2021-2032) Figure 46. Asia Menopause Blood Test Revenue Share by Region (2021-2032) Figure 47. Japan Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Menopause Blood Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Menopause Blood Test Revenue Share by Type (2021-2032) Figure 55. SAMEA Menopause Blood Test Revenue Share by Application (2021-2032) Figure 56. SAMEA Menopause Blood Test Revenue Share by Country (2021-2032) Figure 57. Brazil Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Menopause Blood Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Fingerstick Blood
  • Venous Blood
Applications
  • Premenopausal
  • Postmenopausal
Companies covered
  • Thriva
  • MyHealthChecked
  • Forth
  • Labcorp OnDemand
  • Randox
  • Mina Health
  • OptimallyMe
  • Welzo
  • Quest
  • LifeCell
  • High Trees Clinics
  • Thorne HealthTech
  • Everlywell
  • ZRT Laboratory
  • Medichecks

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Menopause Blood Test Market by Type
  3. 1.2.1 Global Menopause Blood Test Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fingerstick Blood
  5. 1.2.3 Venous Blood
  6. 1.3 Menopause Blood Test Market by Application
  7. 1.3.1 Global Menopause Blood Test Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Premenopausal
  9. 1.3.3 Postmenopausal
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Menopause Blood Test Market Dynamics
  1. 2.1 Menopause Blood Test Industry Trends
  2. 2.2 Menopause Blood Test Industry Drivers
  3. 2.3 Menopause Blood Test Industry Opportunities and Challenges
  4. 2.4 Menopause Blood Test Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Menopause Blood Test Market Perspective (2021-2032)
  2. 3.2 Global Menopause Blood Test Growth Trends by Region
  3. 3.2.1 Global Menopause Blood Test Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Menopause Blood Test Market Size by Region (2021-2026)
  5. 3.2.3 Global Menopause Blood Test Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Menopause Blood Test Revenue by Players
  2. 4.1.1 Global Menopause Blood Test Revenue by Players (2021-2026)
  3. 4.1.2 Global Menopause Blood Test Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Menopause Blood Test Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Menopause Blood Test Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Menopause Blood Test Key Players Headquarters & Area Served
  7. 4.4 Global Menopause Blood Test Players, Product Type & Application
  8. 4.5 Global Menopause Blood Test Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Menopause Blood Test Market CR5 and HHI
  11. 4.6.3 2025 Menopause Blood Test Tier 1, Tier 2, and Tier 3
5 Menopause Blood Test Market Size by Type
  1. 5.1 Global Menopause Blood Test Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Menopause Blood Test Revenue by Type (2021-2032)
  3. 5.3 Global Menopause Blood Test Revenue Market Share by Type (2021-2032)
6 Menopause Blood Test Market Size by Application
  1. 6.1 Global Menopause Blood Test Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Menopause Blood Test Revenue by Application (2021-2032)
  3. 6.3 Global Menopause Blood Test Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thriva
  2. 7.1.1 Thriva Company Information
  3. 7.1.2 Thriva Business Overview
  4. 7.1.3 Thriva Menopause Blood Test Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thriva Menopause Blood Test Product Portfolio
  6. 7.1.5 Thriva Recent Developments
  7. 7.2 MyHealthChecked
  8. 7.2.1 MyHealthChecked Company Information
  9. 7.2.2 MyHealthChecked Business Overview
  10. 7.2.3 MyHealthChecked Menopause Blood Test Revenue and Gross Margin (2021-2026)
  11. 7.2.4 MyHealthChecked Menopause Blood Test Product Portfolio
  12. 7.2.5 MyHealthChecked Recent Developments
  13. 7.3 Forth
  14. 7.3.1 Forth Company Information
  15. 7.3.2 Forth Business Overview
  16. 7.3.3 Forth Menopause Blood Test Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Forth Menopause Blood Test Product Portfolio
  18. 7.3.5 Forth Recent Developments
  19. 7.4 Labcorp OnDemand
  20. 7.4.1 Labcorp OnDemand Company Information
  21. 7.4.2 Labcorp OnDemand Business Overview
  22. 7.4.3 Labcorp OnDemand Menopause Blood Test Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Labcorp OnDemand Menopause Blood Test Product Portfolio
  24. 7.4.5 Labcorp OnDemand Recent Developments
  25. 7.5 Randox
  26. 7.5.1 Randox Company Information
  27. 7.5.2 Randox Business Overview
  28. 7.5.3 Randox Menopause Blood Test Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Randox Menopause Blood Test Product Portfolio
  30. 7.5.5 Randox Recent Developments
  31. 7.6 Mina Health
  32. 7.6.1 Mina Health Company Information
  33. 7.6.2 Mina Health Business Overview
  34. 7.6.3 Mina Health Menopause Blood Test Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Mina Health Menopause Blood Test Product Portfolio
  36. 7.6.5 Mina Health Recent Developments
  37. 7.7 OptimallyMe
  38. 7.7.1 OptimallyMe Company Information
  39. 7.7.2 OptimallyMe Business Overview
  40. 7.7.3 OptimallyMe Menopause Blood Test Revenue and Gross Margin (2021-2026)
  41. 7.7.4 OptimallyMe Menopause Blood Test Product Portfolio
  42. 7.7.5 OptimallyMe Recent Developments
  43. 7.8 Welzo
  44. 7.8.1 Welzo Company Information
  45. 7.8.2 Welzo Business Overview
  46. 7.8.3 Welzo Menopause Blood Test Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Welzo Menopause Blood Test Product Portfolio
  48. 7.8.5 Welzo Recent Developments
  49. 7.9 Quest
  50. 7.9.1 Quest Company Information
  51. 7.9.2 Quest Business Overview
  52. 7.9.3 Quest Menopause Blood Test Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Quest Menopause Blood Test Product Portfolio
  54. 7.9.5 Quest Recent Developments
  55. 7.10 LifeCell
  56. 7.10.1 LifeCell Company Information
  57. 7.10.2 LifeCell Business Overview
  58. 7.10.3 LifeCell Menopause Blood Test Revenue and Gross Margin (2021-2026)
  59. 7.10.4 LifeCell Menopause Blood Test Product Portfolio
  60. 7.10.5 LifeCell Recent Developments
  61. 7.11 High Trees Clinics
  62. 7.11.1 High Trees Clinics Company Information
  63. 7.11.2 High Trees Clinics Business Overview
  64. 7.11.3 High Trees Clinics Menopause Blood Test Revenue and Gross Margin (2021-2026)
  65. 7.11.4 High Trees Clinics Menopause Blood Test Product Portfolio
  66. 7.11.5 High Trees Clinics Recent Developments
  67. 7.12 Thorne HealthTech
  68. 7.12.1 Thorne HealthTech Company Information
  69. 7.12.2 Thorne HealthTech Business Overview
  70. 7.12.3 Thorne HealthTech Menopause Blood Test Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thorne HealthTech Menopause Blood Test Product Portfolio
  72. 7.12.5 Thorne HealthTech Recent Developments
  73. 7.13 Everlywell
  74. 7.13.1 Everlywell Company Information
  75. 7.13.2 Everlywell Business Overview
  76. 7.13.3 Everlywell Menopause Blood Test Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Everlywell Menopause Blood Test Product Portfolio
  78. 7.13.5 Everlywell Recent Developments
  79. 7.14 ZRT Laboratory
  80. 7.14.1 ZRT Laboratory Company Information
  81. 7.14.2 ZRT Laboratory Business Overview
  82. 7.14.3 ZRT Laboratory Menopause Blood Test Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ZRT Laboratory Menopause Blood Test Product Portfolio
  84. 7.14.5 ZRT Laboratory Recent Developments
  85. 7.15 Medichecks
  86. 7.15.1 Medichecks Company Information
  87. 7.15.2 Medichecks Business Overview
  88. 7.15.3 Medichecks Menopause Blood Test Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Medichecks Menopause Blood Test Product Portfolio
  90. 7.15.5 Medichecks Recent Developments
8 North America
  1. 8.1 North America Menopause Blood Test Revenue (2021-2032)
  2. 8.2 North America Menopause Blood Test Revenue by Type (2021-2032)
  3. 8.2.1 North America Menopause Blood Test Revenue by Type (2021-2026)
  4. 8.2.2 North America Menopause Blood Test Revenue by Type (2027-2032)
  5. 8.3 North America Menopause Blood Test Revenue Share by Type (2021-2032)
  6. 8.4 North America Menopause Blood Test Revenue by Application (2021-2032)
  7. 8.4.1 North America Menopause Blood Test Revenue by Application (2021-2026)
  8. 8.4.2 North America Menopause Blood Test Revenue by Application (2027-2032)
  9. 8.5 North America Menopause Blood Test Revenue Share by Application (2021-2032)
  10. 8.6 North America Menopause Blood Test Revenue by Country
  11. 8.6.1 North America Menopause Blood Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Menopause Blood Test Revenue by Country (2021-2026)
  13. 8.6.3 North America Menopause Blood Test Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Menopause Blood Test Revenue (2021-2032)
  2. 9.2 Europe Menopause Blood Test Revenue by Type (2021-2032)
  3. 9.2.1 Europe Menopause Blood Test Revenue by Type (2021-2026)
  4. 9.2.2 Europe Menopause Blood Test Revenue by Type (2027-2032)
  5. 9.3 Europe Menopause Blood Test Revenue Share by Type (2021-2032)
  6. 9.4 Europe Menopause Blood Test Revenue by Application (2021-2032)
  7. 9.4.1 Europe Menopause Blood Test Revenue by Application (2021-2026)
  8. 9.4.2 Europe Menopause Blood Test Revenue by Application (2027-2032)
  9. 9.5 Europe Menopause Blood Test Revenue Share by Application (2021-2032)
  10. 9.6 Europe Menopause Blood Test Revenue by Country
  11. 9.6.1 Europe Menopause Blood Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Menopause Blood Test Revenue by Country (2021-2026)
  13. 9.6.3 Europe Menopause Blood Test Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Menopause Blood Test Revenue (2021-2032)
  2. 10.2 China Menopause Blood Test Revenue by Type (2021-2032)
  3. 10.2.1 China Menopause Blood Test Revenue by Type (2021-2026)
  4. 10.2.2 China Menopause Blood Test Revenue by Type (2027-2032)
  5. 10.3 China Menopause Blood Test Revenue Share by Type (2021-2032)
  6. 10.4 China Menopause Blood Test Revenue by Application (2021-2032)
  7. 10.4.1 China Menopause Blood Test Revenue by Application (2021-2026)
  8. 10.4.2 China Menopause Blood Test Revenue by Application (2027-2032)
  9. 10.5 China Menopause Blood Test Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Menopause Blood Test Revenue (2021-2032)
  2. 11.2 Asia Menopause Blood Test Revenue by Type (2021-2032)
  3. 11.2.1 Asia Menopause Blood Test Revenue by Type (2021-2026)
  4. 11.2.2 Asia Menopause Blood Test Revenue by Type (2027-2032)
  5. 11.3 Asia Menopause Blood Test Revenue Share by Type (2021-2032)
  6. 11.4 Asia Menopause Blood Test Revenue by Application (2021-2032)
  7. 11.4.1 Asia Menopause Blood Test Revenue by Application (2021-2026)
  8. 11.4.2 Asia Menopause Blood Test Revenue by Application (2027-2032)
  9. 11.5 Asia Menopause Blood Test Revenue Share by Application (2021-2032)
  10. 11.6 Asia Menopause Blood Test Revenue by Country
  11. 11.6.1 Asia Menopause Blood Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Menopause Blood Test Revenue by Country (2021-2026)
  13. 11.6.3 Asia Menopause Blood Test Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Menopause Blood Test Revenue (2021-2032)
  2. 12.2 SAMEA Menopause Blood Test Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Menopause Blood Test Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Menopause Blood Test Revenue by Type (2027-2032)
  5. 12.3 SAMEA Menopause Blood Test Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Menopause Blood Test Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Menopause Blood Test Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Menopause Blood Test Revenue by Application (2027-2032)
  9. 12.5 SAMEA Menopause Blood Test Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Menopause Blood Test Revenue by Country
  11. 12.6.1 SAMEA Menopause Blood Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Menopause Blood Test Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Menopause Blood Test Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst